v1
Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma.
Identifier:nobleid.org/w1/20260515/DF46443C
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/DF46443C)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims